ArticleCureus2025
Evaluating the Role of Ultrasonographic Measurements in Assessing Macrosomia Among the Fetuses of High-Risk Antenatal Women in a Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Fetal macrosomia, defined as a birth weight >4.0 kg, is associated with serious maternal and neonatal complications such as prolonged labor, cesarean delivery, postpartum hemorrhage, birth trauma, and long-term metabolic risks. Maternal factors, particularly gestational diabetes mellitus (GDM), excessive weight gain, and certain comorbidities, increase the risk of macrosomia. Early detection in high-risk pregnancies is crucial to guide clinical management and improve outcomes. Conventional sonographic estimated fetal weight (EFW) provides important information but may lack accuracy. Novel markers such as umbilical cord thickness (UCT), fetal fat layer (FFL), and shoulder pad thickness (SPT) have shown potential predictive value. This study aimed to evaluate the accuracy of these sonographic parameters in predicting fetal macrosomia among high-risk pregnancies in a tertiary care setting. Methodology This prospective hospital-based study was conducted at Sree Balaji Medical College and Hospital, Chennai, from July 2023 to June 2024. A total of 100 high-risk antenatal women at 35-36 weeks of gestation were recruited through purposive sampling. Inclusion criteria were pregnancies complicated by GDM, anemia, hypertensive disorders, bronchial asthma, epilepsy, or cardiac conditions. Women with multiple pregnancies, fetal anomalies, or unwillingness to participate were excluded. After informed consent, detailed histories and anthropometric data were recorded, followed by ultrasonographic measurements of UCT, FFL, SPT, and EFW. Outcomes were followed up till delivery. Results Out of the total 100 participants, the majority of women were aged 31-35 years (44%) and primigravida (59%). High-risk conditions included GDM (65%), anemia (16%), and hypertensive disorders (9%). Macrosomia occurred in 49% cases, predominantly among overweight women (37/49, 75.5%), upper socioeconomic class (45/49, 92.3%), and GDM mothers (49/65, 75.4%) (all p<0.001). Male infants were more affected (28/49, 57.1%, p=0.034). UCT >90th percentile, FFL >5 mm, and SPT >12 mm were exclusively associated with macrosomia (all p<0.001). EFW >4.0 kg predicted macrosomia with 100% accuracy. Macrosomia was most frequent in
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.